<DOC>
	<DOC>NCT00664183</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of Vitreosolve in diabetic retinopathy patients.</brief_summary>
	<brief_title>A Safety and Efficacy Study of VitreosolveÂ® for Non-Proliferative Diabetic Retinopathy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Subjects with a history of systemic diabetes (type I or II) Subject with a documented history of Non Proliferative Diabetic Retinopathy (NPDR) Subjects with no PVD at baseline exam in the study eye. Subjects with Retinal pathology in the study eye other than (NPDR) Subjects with high myopia in the study eye Subjects who have monocular vision or contra lateral vision of 20/200 or worse BCVA in the nonstudy eye. Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery less than 6 months prior to study enrollment Subjects that have had either vitrectomy surgery, intravitreal injections, or laser treatments in the study eye.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>diabetic retinopathy</keyword>
</DOC>